Norvaline

Norvaline

SCHEMBL840389

CCC[C@H](N)C(=O)O.CCC[C@H](N)C(=O)O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A2 P43004 5/20 0.64
▸ SLC1A1 P43005 5/20 0.64
▸ SLC1A3 P43003 4/20 0.64
▸ GRIK1 P39086 4/20 0.64
▸ GRIK2 Q13002 4/20 0.64
▸ GSR P00390 2/20 0.56
▸ GRM8 O00222 1/20 0.56
▸ GRM6 O15303 1/20 0.56
▸ GRIN2D O15399 1/20 0.56
▸ GRIN3B O60391 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ GRM5 P41594 1/20 0.56
▸ GRIA1 P42261 1/20 0.56
▸ GRIA2 P42262 1/20 0.56
▸ GRIA3 P42263 1/20 0.56
▸ GRIA4 P48058 1/20 0.56
▸ GRIN1 Q05586 1/20 0.56
▸ GRIN2A Q12879 1/20 0.56
▸ GRIK3 Q13003 1/20 0.56
▸ GRIN2B Q13224 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Norvaline SCHEMBL542602 1.00 SLC1A2 (0.64) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
Norvaline SCHEMBL17449755 1.00 — —
Norvaline SCHEMBL38405 1.00 — —
Norvaline SCHEMBL197812 1.00 — —
Norvaline SCHEMBL38404 1.00 — —
Norvaline SCHEMBL21114359 1.00 SLC1A2 (0.64) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
Norvaline SCHEMBL28670644 0.97 SLC1A2 (0.61) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
Norvaline SCHEMBL28394825 0.97 — —
Norvaline SCHEMBL30692359 0.97 — —
Norvaline SCHEMBL4155453 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016183093-A1 INHIBITORS OF VIRUSES UNIVERSITY OF KANSAS (US) 2016-11-17 — — WO disclosed
US-8143448-B2 Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives VIROBAY, INC. (US) 2012-03-27 — — US disclosed
Send feedback